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Abstract 
Background: Cystic echinococcosis is an important zoonosis caused by the 
Echinococcus granulosus with a substantial impact in human and animal health in en-
demic areas. The purpose of the present study was serodiagnosis optimizing of 
dog echinococcosis in order to achieve a rapid diagnostic method.  
Methods: Eight dogs were challenged with protoscoleces in order to have posi-
tive echinococcosis serum and 2 two-month old puppies were used as uninfected 
controls. Colloidal gold was prepared by controlled reduction of a boiling solu-
tion of chloroauric acid (H [AuCl4]) with sodium citrate and labeled with recom-
binant EPC1. Dot immunogold filtration assay (DIGFA) was developed by coat-
ing rEPC1 labeled colloidal gold on nitrocellulose membrane. The canine sera, 
taken three times including, 15, 28 and 35 days post infection were tested. A total 
of 30 serum samples including 24 sera from 8 infected dogs and 6 sera from 2 
puppies were comparatively detected with both DIGFA and ELISA.  
Results: Gold labeled antigen, showed a dark purple dot with agglutination parti-
cles in positive sera and light purple dot without agglutination in negative sera. 
Among 30 serum samples, 23 were positive and 7 were negative with DIGFA and 
24 were positive, 6 were negative with ELISA.  
Conclusion: DIGFA as a rapid and simple procedure could be utilized in quickly 
diagnosis of echinococcosis.  
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Introduction 
 
ystic echinococcosis (CE) is a zoono-
sis caused by the metacestode of 
Echinococcus granulosus. In Iran, this 
cestode is commonly found in all provinces, 
while it is usually maintained through a do-
mestic life cycle involving dogs and sheep (1, 
2). 
CE is still one of the health and economic 
problems in developing countries, where it 
causes mortality both in humans and animals 
(3, 4). It remains one of the most important 
zoonoses in Iran yet (5). 
 Moreover, direct and indirect losses in vet-
erinary industry are reported annually. Direct 
losses are calculated on the base of con-
demned organs, while indirect losses are ex-
pected based on live weight loss caused by 
hydatidosis (6). 
In Iran hydatidosis (both in human and ani-
mal) is due to G1 (sheep strain), G6 (camel 
strain) and G3 (buffalo) strains of Echinococcus 
granulosus (7). CE diagnosis is mostly based on 
imaging techniques (8). 
. While CE is often diagnosed by imaging 
methods, that most notably included CT scan 
and Sonography but serological test is also 
very considerable.  
 Therefore, there is a need for standardized 
and approachable diagnostic tools, which may 
complement imaging data. An immunoassay 
can be used as a confirmatory test, usually 
consisted of E. granulosus recombinants anti-
gens. Several recombinant antigens have 
shown potential for CE serodiagnosis (9). Re-
liable test with accepted sensitivity and speci-
ficity for the serodiagnosis of human cystic 
echinococcosis (CE) and dog echinococcosis 
is still needed, because of the low specificity 
and sensitivity of the currently available com-
mercial tools. Developing a rapid, simple, sen-
sitive, specific and convenient immmunologi-
cal assay is a crucial step. 
The dot immunogold filtration assay which 
has been in use since 1989 is a technique with 
the property of simple and rapid immunologi-
cal detection, by using the red colloidal gold 
particles to label the antibodies/antigens as 
indicator, and a nitrocellulose membrane coat-
ed with antigen as the carrier. Affected by fil-
tration and condensation, the antigen antibody 
reaction occurs rapidly. When the reaction is 
positive, red to purple dots appear on the 
membrane. It takes about 2 min to 4 min for 
the whole reaction to be carried out. With the 
above technique, we have optimized the dot 
immunogold filtration assay (DIGFA) for rap-
id detection of specific IgGs in dogs infected 
with Echinococcus granulosus. DIGFA is a highly 
sensitive and specific assay when it is used to 
detect anti-parasite antibodies (10- 13). In the 
present study, the capacity of labeled recom-
binant EPC1 with nano gold particles to diag-
nose CE was assessed based on DIGFA 
method and the diagnostic performance was 
compared with ELISA. 
Serodiagnosis optimizing of dog echoino-
coccosis was the aim of the present article in 
order to achieve a rapid and accessible diagno-
sis method in the field.  
Although recombinant antigens with poten-
tial to replace native antigens have been pro-
posed in the literature, none has been system-
atically tested for diagnostic performance. 
Thus, in this study, we produced a re-
combinant antigen EPC1 from protoscoleces 
for the diagnosis and monitoring of echino-
coccosis. 
 
Materials and Methods 
 
Dogs experimental infection 
This work was performed as a cross- sec-
tional study on ten dogs (2-3 months old). 
Dogs were labeled in two groups. The first 
group (8 dogs) was inoculated with 90000-
100000 (viability more than 85%) protoscole-
ces. Each dog was fed about 100000 protosco-
leces. The second group, as negative controls 
C 
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(2 puppies), was kept in the same condition as 
the first group but not fed any protoscolex. 
Blood samples were collected three times in-
cluding, 15, 28 and 35days post infection. The 
blood was clotted at room temperature for 30 
minutes and then at 4 °C for 4 hours. The clot 
was separated from the serum by centrifuga-
tion at 3,000× g for 10 minutes and the serum 
stored in 1ml aliquots at -20°C, until use 
On day 35 after challenged, each dog was 
euthanized by intravenous injection of an 
overdose of Sodium Pentobarbital for nec-
ropsy. The presence of adult Echinococcus granu-
losus was confirmed in the intestines contents 
of the first group.  
 
Recombinant protein EPC1 
Recombinant EPC1 (rEPC1) was produced 
according to method previously reported (14). 
Briefly Liver and lung hydatid cysts from natu-
rally infected sheep were collected from 
slaughterhouses in the vicinity of Tehran city, 
Iran. Protoscoleces were aspirated from cysts, 
pooled, and washed in phosphate buffered 
saline (PBS- 1%). Total RNA was extracted 
immediately from protoscoleces using a RNe-
asy minikit (Qiagen, Germany) according to 
the manufacturer instruction. Then cDNA 
was synthesized using Reverse Transcriptase 
(Fermentas, Lithuania). The EPC1 gene of E. 
granulosus was amplified by PCR. PCR product, 
a band of 228 bp, was digested with BamHΙ 
and EcoRΙ and consequently the expression 
plasmid vector pET28a was double digested 
with the same restriction endonucleases as 
mentioned above. The EPC1-cDNA product 
was cloned in the multicloning site (BamHI 
and EcoRΙ site) of pET28a plasmid using rapid 
DNA ligation kit (Roche, Germany).  
In order to express rEPC1, recombinant 
plasmid pET28a containing the EPC1 was 
transformed into competent E. coli BL21 cells. 
Then the recombinant plasmid extracted from 
transformed E. coli BL21 was digested by the 
restriction enzymes EcoRI and BamHI, which 
confirmed the successful construction of the 
recombinant expression plasmid EPC1/ 
pET28a.  
After that, Protein expression was induced 
at 33°C for 6 h in the presence of isopropyl-b-
D-thiogalactoside (IPTG) at a final concentra-
tion of 0.5 mM.  
The recombinant His6-tagged EPC1 was 
purified from the extract of transformed E. 
coli BL21 by Ni-NTA agarose Kit (Qiagen, 
Germany) according to the manufacturer’s 
instructions. The purified His6-tagged protein 
was analyzed on a 12% sodium dodecyl sul-
fate–polyacrylamide gel electrophoresis (SDS–
PAGE) gel. Western blot analysis was done 
with HRP-conjugated mouse anti-T7 tag at a 
1:5000 dilution. Finally, the positive reaction 
was developed using DAB (3, 3'-
diaminobenzidine) (Sigma_Aldrich, USA) as 
substrate under visual observation within 5 
min. 
 
Indirect ELISA 
ELISA was conducted as reported earlier 
(15). Briefly, 96-well polystyrenes microtiter 
plates were coated with rEPC1 (5 µg/well). 
Horseradish peroxidase (HRP)-conjugated 
rabbit anti-dog IgG (Sigma_Aldrich) at a 
1:10000 dilution was used as secondary anti-
body. Collected dog sera were evaluated and 
consequently it was shown that rEPC1 was 
able to distinguish positive echinococcosis 
sera (first dogs group) from negative control. 
 
Preparation of Colloidal gold  
Colloidal gold solutions were prepared ac-
cording to the methods by Frens (16) Gold 
nano particles were produced by reductio-
n of chloroauricacid (H [AuCl4]). After dissolv-
ing of 0.01gr H [AuCl4] in 100 ml H2O, a yel-
low color appeared; 50 ml of the solution was 
rapidly stirred and heated to the boiling point 
with 1 ml of 10 g/L sodium citrate as a reduc-
ing agent. Sodium citrate causes Au3+ ions to 
be reduced to neutral gold atoms. As more and 
more of these gold atoms formed, the solution 
became supersaturated, and gold gradually 
started to precipitate in the form of sub-na-
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nometer particles. The boiling lasted 5 min. 
While the solution was stirred vigorously, the 
particles became fairly uniform in size. The 
preparation was finished when the solution 
became dark red in color. 
 
Wavelength Spectrum of Colloidal gold 
According to Rance, the nano gold particles 
of 20-22 nanometer size show the maximum 
absorption in the wavelength of 525 nanome-
ter (17). In the present study the absorption of 
nano gold particles was measured. Since the 
particles showed the maximum optical density 
in the wavelength of 520 nanometer, those 
probably were 20-22 nanometers in size which 
indicating that the colloid gold met the experi-
mental requirements. 
 
Recombinant EPC1colloidal gold labeling 
The protein was labeled with colloidal gold 
as follows: 250 µl of recombinant EPC1 was 
added to 12 ml of liquid contains Colloidal 
gold with the help of magnetic stirring. The 
pH of 1 ml colloidal gold adjusted to a pH of 
8.8 using 0.1 mol/L K2CO3. After 10 min, 
bovine serum albumin (BSA) was added to get 
the concentration of 10 g/L. After that, the 
mixture was centrifuged at 13000 × g for 15 
min. The supernatant was discarded and the 
precipitate was dissolved by 5 g/L BSA-PBS, 
thus forming the colloidal gold labeling rea-
gent (Fig.1). 
DIGFA procedure 
The nitrocellulose membrane (which is used 
as basic membrane in DIGFA and can con-
centrate gold probes) was divided by pencil 
into 1 cm squares. A drop of the labeled 
rEPC1 (about 5μl) was spotted with a mi-
cropipette onto the center of each small 
square and the paper was dried at room tem-
perature (RT) and stored at 4ºC over night.  
The paper was rinsed with the PBS-T twice 
for 10 min each time at RT. 
After being dried, 10 μl of dog serum was 
dripped slowly to the center of the membrane 
and membrane was incubated at RT for 3 
minutes without any washing after adding the 
sera. The canine sera were tested by different 
concentration 1:10, 1:50, 1:100 and 1:200. 
 
Results 
 
Recombinant EPC1 
Figure 1 shows three bands of 228 bp repre-
senting the PCR products of EPC1. Enzyme 
digestion of recombinant plasmid confirmed 
that ligation was done successfully (Fig. 2). 
The SDS–PAGE staining results demon-
strated that the His-tagged EPC1 protein was 
expressed in BL21 cells, a band of 12.8 kDa 
(Fig.3). Also the result of purified EPC1 West-
ern blot analysis using T7 tag antibody shows 
a specific band of 12.8 kDa (Fig. 4). 
 
 
 
Fig.1: Lane 1: 100 bp DNA Ladder, Lane2, 3 & 4 
EPC1 gene PCR products 
 
 
Fig. 2: Digestion of recombinant plasmid 
pET28a/EPC1 by EcoRI and Bam 
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Fig. 3: SDS–PAGE analysis of the rEPC1. The 
gel was Coomassie brilliant blue-stained., the ex-
pected molecular mass of the His6-tagged 
rEPC1protein was 12.8 kDa. M, protein marker; 
lane 1: Escherichia coli lysates with IPTG 0.5 mM 
after 6 h of induction, lane 2: Escherichia coli lysates 
with IPTG 1 mM after 6 h of induction, Lane 3 
and 4: rEPC1protein extracts, lane 5: Escherichia coli 
lysates without IPTG induction 
 
Spectrophotometric analysis results  
The influence of 20nm gold nanoparticle 
size on the absorbance density is illustrated in 
Fig. 5. It is revealed that absorption maximum 
increases to 520nm. 
 
 
Fig. 4: Western blot analysis of rEPC1. M: protein 
marker; Lane 1; the protein rEPC1was immunob-
lotted with pooled T7 tag antibody 
 
Dot intensity of DIGFA. 
The intensity of the dot color was judged 
with naked eye (Fig.6). Positive results were 
decided by the appearance of regular, round, 
dark purple dot at the center of the square 
with agglutination particles whereas the nega-
tive squares appeared light purple as we ex-
pected since the rEPC1 became purple after 
nano gold labeling process.  
 
 
 
Fig. 5: UV-vis absorption spectra of colloidal gold nano particle in different Wavelengths 
 
Sensitivity and specificity of DIGFA and 
ELISA  
The results of DIGFA and ELISA assays 
for dog sera are shown in Table 1. 
Between 24 sera taken from 8 infected dogs, 
23 exhibited dot reaction in DIGFA with opti-
mal results obtained from 1:50 serum dilution 
and one showed no reaction. Furthermore, 
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two uninfected dogs did not indicate any reac-
tion.  
All infected dogs demonstrated anti-rEPC1 
antibody response in ELISA test and the 2 
negative control dogs were negative. The sen-
sitivity and specificity of the two assays are 
compared in Table 1. As can be seen the nega-
tive rate between the two assays was the same 
while there was a poor difference in the posi-
tive rate. Nevertheless, this difference between 
sensitivity in mentioned two methods was due 
to serum samples limitation. Subsequently 
large number of sera is needed to have a more 
trustworthy and constant comparable evalua-
tion of these two techniques.  
 
 
 
Fig. 6: –Some of the positive and negative results of DIGFA with dogs positive and negative sera (dilution of 
1:50) in different days post infection. Round, dark purple dot at the center of the square with agglutination 
particles can be seen in positive samples. In negative samples, a color of light purple is seen which is belong to 
the colloidal gold 
 
Table 1: Comparison of the results detected by ELISA and DIGFA in dogs serum samples 
 
  ELISA* DIGFA 
 
Cases 
Serum 
samples 
No. of positive 
 
No. of Negative 
 
No. of positive No. of Negative 
 
Infected 24 24 - 23 1 
Non infected 6 - 6 - 6 
Total 30 24 6 23 7 
* ELISA results are based on the study outcome, which has been done recently (10). Sensitivity, specificity 
derived from analysis of rEPC1 in DIGFA against sera from dogs are reported respectively, 96% and 100% 
and indirect ELISA showed sensitivity, specificity of 100%, 100%. 
 
Discussion 
 
Accurate diagnosis of the infection in the 
definitive host plays a central role in epide-
miological studies and for surveillance of hy-
datid control programs (8). 
Current serological methods for detecting 
dog echinococcosis are too limited and this 
inadequacy is considered as an important issue. 
EPC1 as a recombinant protein has been in-
troduced as one of the admissible candidates 
in hydatidosis/echinococcosis detection (18). 
The necessity of an uncomplicated, rapid, 
and non-instrumented test is obvious in many 
basic units, where laboratory facilities and 
trained personnel are limited. The dot immu-
nogold test is a new immunological technique, 
which has been developed in recent years (13-
19-20). Since the nitrocellulose membrane not 
only absorbs protein, but also affords rapid 
filtration and acts as capillaries, the antibody in 
serum is able to combine rapidly with the 
counterpart on the membrane. Moreover, as 
the colloidal gold labeling reagent is red in 
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color, red dots appear after the combination 
takes place. Therefore, no color-developing 
reagent is needed (19). 
In 1989, Chun developed DIGFA as (21) a 
rapid test, to detect HCG, C-reactive protein, 
immunoglobulin G antibody and others (22, 
23). 
In 1999, DIGFA was developed and evalu-
ated for detection of anti-HAV IgM (24). In 
1996, Huang et al. developed DIGFA as a 
simple, rapid, and reproducible test for the 
rapid detection of reaginic antibody in the se-
rum of syphilitic patients. Subsequently the 
levels of agreement between DIGFA and the 
rapid regain test and between DIGFA and the 
fluorescent treponemal antibody-absorption 
test were 100 and 98%, respectively. Regard-
ing the results of clinical application, they indi-
cated that DIGFA could be used as a routine 
screening test for syphilis (25).  
Ye et al. used DIGFA as a rapid and cost-ef-
fective screening tool for the determination of 
aflatoxin B (1) in foods in the field within 
15min without complicated steps (26). 
Wang et al. developed DIGFA to detect 
white spot syndrome virus of shrimp. They 
showed that the sensitivity of DIGFA is simi-
lar to dot-blot nitrocellulose enzyme immuno-
assay while DIGFA can be performed con-
veniently pond side providing a faster result 
without the production of false positive results 
(27). 
This method, which has aroused our interest 
greatly, keeps not only with the sensitivity and 
specificity of the ELISA, but also with the ad-
vantage of affording prompt result. Actually, 
the disadvantages of ELISA lie on its require-
ment of prolonged operation time, compli-
cated procedures and instruments. Our results 
showed that compared with ELISA, DIGFA 
had relatively similar results, but with signifi-
cantly much shorter time. We considered that 
DIGFA assay was not only very fast and sim-
ple, but also considerably stable, sensitive, spe-
cific, and practical.  
Overall, the advantages in using DIGFA to 
test the Anti-rEPC1 IgG are as follows: The 
operation period is shortened from a few 
hours to 5 min and the results are reliable and 
visible to the naked eye. The specificity and 
sensitivity are approximately equal to those of 
the ELISA. The rEPC1is coated on the nitro-
cellulose millipore filtering membrane in a sol-
id phase, with durable activity; the colloidal 
gold labeling reagent can be preserved beyond 
one year; the manipulations are simple and no 
sophisticated testing instrument required; the 
operator can be trained in a simple way. Final-
ly, DIGFA is an ideal, rapid and simple pro-
cedure, with the visual interpretation of results 
that can be utilized in quickly diagnosis of hy-
datidosis/echinococcosis both in field situa-
tion and in the clinic. 
Results obtained from used method (DIG-
FA) in this study are relatively similar to Dot-
ELISA results, while blocking and washing 
steps, which should be done in dot-ELISA, 
are not needed in this method. Moreover, no 
secondary antibody is used in DIGFA. So 
DIGFA could be done in shorter time in 
compare to dot-ELISA.   
It should be noticed that such method, 
which its results are, reported ocular could be 
affected by any kind of mistake. Since rEPC1 
labeled with colloidal gold has a base color of 
purple and this color is seen always on the pa-
per, then in order to distinguish negative from 
positives results, there should be always a neg-
ative and a positive control beside any test. 
Nevertheless, in future supplementary stud-
ies, in order to standardization of this method 
cross-reactions should be studied with dog 
sera infected with other parasites and infec-
tions. 
At the same time as infected dogs are usually 
herd dogs or guard dogs and this needs a rapid, 
simple and possible screening technique, 
hence mentioned method in this study could 
be a appropriate candidate.   
 
Conclusion 
 
Since dog has primary role in the transmis-
sion dynamics of CE, detection of E. granu-
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losus in the definitive host plays a significant 
role in implementing hydatid control pro-
grams. So a rapid and simple procedure, with 
the visual interpretation of results and reagent 
stability with the aid of nano particles could be 
particularly suitable for field testing and epi-
demiological surveys.   
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